Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1275-1279

  Wijnholds, Jan ^a   Evers, Raymond ^a   Van Leusden, Manuel R ^a   Mol, Carla A A M ^a   Zaman, Guido J R ^a,c   Mayer, Ulrich ^a,d   Beijnen, Jos H ^b   Van Der Valk, Martin ^a   Krimpenfort, Paul ^a   Borst, Piet ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c Dept of Biotech and Biochemistry ^*  (Netherlands)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; ETOPOSIDE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 20244386956     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1275     Document Type: Article

References (29)

1. Zaman, G.J.R. & Borst, P. MRP, mode of action and role in MDR. in Multidrug Resistance in Cancer Cells (eds. Gupta, S. & Tsuruo, T) 95-107 (Wiley & Sons, London, 1996).
2. Loe, D.W., Deeley, R.G. & Cole, S.P.C. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer 32A, 945-957 (1996).
3. 4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810 (1994).
4. Cole, S.P.C. et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654 (1992).
5. Jedlitschky, G. et al. Transport of gluthathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56, 988-994 (1996).
6. Flens, M.J. et al. Distribution of the multidrug resistance-associated protein (MRP) in normal and malignant human tissues. Am. J. Pathol. 148, 1237-1247 (1996).
7. Ishikawa, T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17, 463-468 (1992).
8. Saxena, M. & Henderson, G.B. MOAT4, a novel multispecific organic-anion transporter for glucuronides and mercapturates in mouse L1210 cells and human erythrocytes. Biochem. J. 320, 273-281 (1996).
9. Gottesman, M.M., Hrycyna, C.A., Schoenlein, P.V., Germann, U.A. & Pastan, I. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29, 607-649 (1995).
10. Müller, M. et al. Overexpression of the gene encoding the multidrug resistance associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91, 13033-13037 (1994).
11. Zaman, G.J.R., Cnubben, N.H.P., Bladeren, P.J., Evers, R. & Borst, P. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP. FEBS Lett. 391, 126-130 (1996).
12. Zaman, G.J.R. et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA 91, 8822-8826 (1994).
13. Pulaski, L., Jedlitschy, G., Leier, I., Buchholz, U. & Keppler, D. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 241, 644-648 (1996).
14. 4. Proc. Natl. Acad. Sci. USA 89, 11598-11602 (1992).
15. Domen, J. et al. Impaired interleukin-3 response in pim-1-deficient bone marrow-derived mast cells. Blood 82, 1445-152 (1993).
16. 4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc. Natl. Acad. Sci. USA 79, 4665-4667 (1982).
17. Paulusma, C.C. et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271, 1126-1128 (1996).
18. Hay, D.W.P., Torphy, T.J. & Undem, B. J. Cysteinyl leukotrienes in asthma: Old mediators up to new tricks. Trends Pharmacol. Sci. 16, 304-309 (1995).
19. Chen, X.-S., Sheller, J.R., Johnson, E.N. & Funk, C.D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372, 179-182 (1994).
20. Goulet, J.L., Snouwaert, J.N., Latour, A.M., Coffman, T.M. & Koller, B.H. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91, 12852-12856 (1994).
21. Opas, E.E., Bonney, R.J. & Humes, J.L. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J. Invest. Dermatol. 84, 253-256 (1985).
22. Cole, S.P.C. et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54, 5902-5910 (1994).
23. Lorico, A., Rappa, G., Flavell, R.A. & Sartorelli, A.C. Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res. 56, 5351-5355 (1996).
24. Ishikawa, T. et al. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271, 14981-14988 (1996).
25. Zaman, G.J.R. et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA 92, 7690-7694 (1995).
26. Schinkel, A.H. et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94, 4028-4033 (1997).
27. Schinkel, A.H. et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502 (1994).
28. Stride, B.D. et al. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49, 962-971 (1996).
29. 4, using octadecyl reversed-phase extraction columns. J. Chromatogr. 378, 208-214 (1986).